Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics

BACKGROUND: In approximately 80% of patients, ovarian cancer is diagnosed when the patient is already in the advanced stages of the disease. CA125 is currently used as the marker for ovarian cancer; however, it lacks specificity and sensitivity for detecting early stage disease. There is a critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetty, Vivekananda, Hafner, Julie, Shah, Punit, Nickens, Zacharie, Philip, Ramila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488482/
https://www.ncbi.nlm.nih.gov/pubmed/22856521
http://dx.doi.org/10.1186/1559-0275-9-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488482/
https://www.ncbi.nlm.nih.gov/pubmed/22856521
http://dx.doi.org/10.1186/1559-0275-9-10

Ejemplares similares